Press Release https://www.myesr.org/taxonomy/term/47 en European Society of Radiology makes high-quality educational services free to all to aid the fight against COVID-19 https://www.myesr.org/article/3197 <span property="schema:name">European Society of Radiology makes high-quality educational services free to all to aid the fight against COVID-19</span> <span rel="schema:author"><span title="View user profile." href="/user/1" lang="" about="/user/1" typeof="schema:Person" property="schema:name" datatype="">myESR</span> </span> <span property="schema:dateCreated" content="2020-03-25T13:07:58+00:00">Wed, 03/25/2020 - 14:07</span> <div class="row p-relative"> <div class="col-xs-12 col-sm-12 col-md-12"> <p>The <a href="http://www.myesr.org/" target="_blank">European Society of Radiology (ESR)</a> has made the decision to make its high-quality content on <a href="https://connect.myesr.org/">ESR Connect</a> and <a href="https://learn-myesr.talentlms.com/index">Education on Demand</a> free for all. This decision comes amidst a growing need for radiology to unite as a profession in order to tackle the great challenges that the world is currently facing. The services, which will include full access to quality e-learning content, will be available for the next four weeks. The ESR has worked as fast and efficiently as possible to ensure that the services are available at very short notice.</p> <p>The ESR understands that radiologists have a very significant role to play in the fight against COVID-19, helping to diagnose the disease, track its development and assess the effectiveness of various trial treatments for the virus. In keeping with its commitment to supporting the radiological profession, the ESR will offer free access to services which were previously only accessible with a subscription. On ESR Connect, entire topic packages with hundreds of hours of video material will be accessible, whilst on Education on Demand an extraordinary range of self-assessment, literature, video and European School of Radiology (ESOR) courses have been moved from the premium section to the free-to-use section with more content set to be added regularly.</p> <p>Please see detailed information on how to access both platforms further below.</p> <p>It is the society’s hope that this content will be used by radiologists and other healthcare practitioners across the world to help further educate themselves and others in a diverse and interesting selection of imaging disciplines and subspecialties.</p> <p>The European Society of Radiology thanks all those who are currently working in healthcare for their service, bravery and commitment to fighting COVID-19 at this time. Even though much of the world is now engulfed in an unparalleled struggle with this novel disease, the society trusts that together we will overcome it, emerging stronger and more united than ever before.<br />  </p> <h5>How to access Education on Demand for free</h5> <p>To make it as convenient as possible we have moved an extraordinary range of self-assessment, literature, video and European School of Radiology (ESOR) courses from the premium section to the <a href="https://learn-myesr.talentlms.com/index" target="_blank">free-to-use section</a> with more content set to be added regularly.</p> <p>Just scroll through the course catalogue and choose from more than 100 courses.<br />  </p> <h5>How to access ESR Connect for free</h5> <p>Just login with your ESR MyUser account or if you do not have one yet, create an account directly on the <a href="https://connect.myesr.org/" target="_blank">ESR Connect platform</a>. </p> <p>Once you are logged in, all topic packages with hundreds of hours of video material and all other on-demand recordings are available free of charge</p> </div> </div> <i class="banner-image force-fullsize"> <picture> <!--[if IE 9]><video style="display: none;"><![endif]--> <source srcset="/sites/default/files/styles/header_sm_min_width_1200px/public/2018-06/MYESR_PageBanner6_web.jpg?itok=oiMSj_3M 1x" media="all and (min-width: 1200px)" type="image/jpeg"/> <source srcset="/sites/default/files/styles/header_sm_max_width_1199px/public/2018-06/MYESR_PageBanner6_web.jpg?itok=9DrsuzsI 1x" media="all and (max-width: 1199px)" type="image/jpeg"/> <source srcset="/sites/default/files/styles/header_sm_max_width_1199px/public/2018-06/MYESR_PageBanner6_web.jpg?itok=9DrsuzsI 1x" media="all and (min-width: 992px)" type="image/jpeg"/> <source srcset="/sites/default/files/styles/header_sm_max_width_991px/public/2018-06/MYESR_PageBanner6_web.jpg?itok=sKnv3ZpR 1x" media="all and (max-width: 991px)" type="image/jpeg"/> <source srcset="/sites/default/files/styles/header_sm_max_width_991px/public/2018-06/MYESR_PageBanner6_web.jpg?itok=sKnv3ZpR 1x" media="all and (min-width: 768px)" type="image/jpeg"/> <source srcset="/sites/default/files/styles/header_sm_max_width_767px/public/2018-06/MYESR_PageBanner6_web.jpg?itok=mDUCNuR1 1x" media="all and (max-width: 767px)" type="image/jpeg"/> <!--[if IE 9]></video><![endif]--> <img src="/sites/default/files/styles/header_sm_max_width_767px/public/2018-06/MYESR_PageBanner6_web.jpg?itok=mDUCNuR1" alt="MYESR_PageBanner6_web.jpg" typeof="foaf:Image" class="img-responsive" /> </picture> </i> <span class="a2a_kit a2a_kit_size_32 addtoany_list" data-a2a-url="https://www.myesr.org/article/3197" data-a2a-title="European Society of Radiology makes high-quality educational services free to all to aid the fight against COVID-19"><a class="a2a_button_facebook"></a><a class="a2a_button_twitter"></a></span> Wed, 25 Mar 2020 13:07:58 +0000 myESR 3197 at https://www.myesr.org United behind science – World leading geneticist to give lecture on potential COVID-19 treatment https://www.myesr.org/article/3194 <span property="schema:name">United behind science – World leading geneticist to give lecture on potential COVID-19 treatment</span> <span rel="schema:author"><span title="View user profile." href="/user/1" lang="" about="/user/1" typeof="schema:Person" property="schema:name" datatype="">myESR</span> </span> <span property="schema:dateCreated" content="2020-03-09T15:15:08+00:00">Mon, 03/09/2020 - 16:15</span> <div class="row p-relative"> <div class="col-xs-12 col-sm-12 col-md-12"> <p><strong>Addressing the ongoing developments and challenges for public health related to the 2019 novel coronavirus disease (COVID-19), the <a href="https://myesr.us16.list-manage.com/track/click?u=f0e155f988768a8aa22785eab&amp;id=5df29eb9a8&amp;e=5d1926846e">European Society of Radiology (ESR)</a> will be hosting a top-class online event on the disease on March 12, featuring Prof. Josef Penninger, a world-leading geneticist and immunologist. </strong><br /> <br /> <strong>Despite the <a href="https://myesr.us16.list-manage.com/track/click?u=f0e155f988768a8aa22785eab&amp;id=91916d4836&amp;e=5d1926846e">postponement of the European Congress of Radiology (ECR) 2020</a>, the ESR remains fully committed to supporting the fight against COVID-19 through science and research. For this reason, the session on COVID-19 will be made available to all, streamed live and free-of-charge from the ESR studio in Vienna on Thursday, March 12 at 17:00 CET.</strong><br /> <br /> The event will feature the lecture, “ACE2 – a rational frontline therapy for COVID-19” given by Austrian scientist Prof. Josef Penninger, one of the world’s leading geneticists and molecular immunologists. He will aim to shed light on the discovery and function of ACE2 (angiotensin converting enzyme 2) and will also cover the relationship between ACE2 and the renin-angiotensin system (RAS), a hormone system responsible for systemic vascular resistance and for regulating blood pressure and fluid-electrolyte balance in instances of lung injury. He will highlight the predisposition of ACE2 as a SARS-CoV and SARS-CoV-2 receptor and therefore as a potential treatment approach.<br /> <br /> A recipient of numerous prestigious prizes, Penninger established the Viennese Institute of Molecular Biotechnology, and is the current Director of the Life Sciences Institute at the University of British Columbia in Vancouver, Canada. The main focus of his work has been autoimmune, bone, heart and lung diseases, and cancers. APEIRON Biologics AG, a company Penninger founded, is currently tackling the ongoing outbreak of COVID-19 in China and started a pilot clinical trial for their newly developed drug that is supposed to decrease mortality in those affected by the virus.<br /> <br /> The session at the ESR Studio will be hosted by Austrian radiologist, Prof. Christian Loewe and will include the opportunity for viewers to ask live questions. For further details about the session, click <a href="https://myesr.us16.list-manage.com/track/click?u=f0e155f988768a8aa22785eab&amp;id=a44eb14531&amp;e=5d1926846e">here</a>.<br /> <br /> The decision to make this event publicly available is in keeping with the ESR’s continued commitment to bringing the latest scientific developments to its members and the public. During these challenging times, not only for the ESR and ECR but also for the world over, the society wishes to help in any way it can to fight the coronavirus outbreak, and its commitment to science and public health remains its No.1 priority.<br /> <br /> The online event will be streamed live via ESR Connect. You can register for the event now by clicking <a href="https://myesr.us16.list-manage.com/track/click?u=f0e155f988768a8aa22785eab&amp;id=a207f57ceb&amp;e=5d1926846e">here</a>.</p> </div> </div> <i class="banner-image force-fullsize"> <picture> <!--[if IE 9]><video style="display: none;"><![endif]--> <source srcset="/sites/default/files/styles/header_sm_min_width_1200px/public/2018-06/MYESR_PageBanner6_web.jpg?itok=oiMSj_3M 1x" media="all and (min-width: 1200px)" type="image/jpeg"/> <source srcset="/sites/default/files/styles/header_sm_max_width_1199px/public/2018-06/MYESR_PageBanner6_web.jpg?itok=9DrsuzsI 1x" media="all and (max-width: 1199px)" type="image/jpeg"/> <source srcset="/sites/default/files/styles/header_sm_max_width_1199px/public/2018-06/MYESR_PageBanner6_web.jpg?itok=9DrsuzsI 1x" media="all and (min-width: 992px)" type="image/jpeg"/> <source srcset="/sites/default/files/styles/header_sm_max_width_991px/public/2018-06/MYESR_PageBanner6_web.jpg?itok=sKnv3ZpR 1x" media="all and (max-width: 991px)" type="image/jpeg"/> <source srcset="/sites/default/files/styles/header_sm_max_width_991px/public/2018-06/MYESR_PageBanner6_web.jpg?itok=sKnv3ZpR 1x" media="all and (min-width: 768px)" type="image/jpeg"/> <source srcset="/sites/default/files/styles/header_sm_max_width_767px/public/2018-06/MYESR_PageBanner6_web.jpg?itok=mDUCNuR1 1x" media="all and (max-width: 767px)" type="image/jpeg"/> <!--[if IE 9]></video><![endif]--> <img src="/sites/default/files/styles/header_sm_max_width_767px/public/2018-06/MYESR_PageBanner6_web.jpg?itok=mDUCNuR1" alt="MYESR_PageBanner6_web.jpg" typeof="foaf:Image" class="img-responsive" /> </picture> </i> <span class="a2a_kit a2a_kit_size_32 addtoany_list" data-a2a-url="https://www.myesr.org/article/3194" data-a2a-title="United behind science – World leading geneticist to give lecture on potential COVID-19 treatment"><a class="a2a_button_facebook"></a><a class="a2a_button_twitter"></a></span> Mon, 09 Mar 2020 15:15:08 +0000 myESR 3194 at https://www.myesr.org Guerbet offers a unique experience at Tech Gate during ECR 2020 https://www.myesr.org/article/3179 <span property="schema:name">Guerbet offers a unique experience at Tech Gate during ECR 2020</span> <span rel="schema:author"><span title="View user profile." href="/user/1" lang="" about="/user/1" typeof="schema:Person" property="schema:name" datatype="">myESR</span> </span> <span property="schema:dateCreated" content="2020-02-17T19:00:55+00:00">Mon, 02/17/2020 - 20:00</span> <div class="row p-relative"> <div class="col-xs-12 col-sm-12 col-md-12"> <p> </p> <img alt="Guerbet logo" data-entity-type="file" data-entity-uuid="8c176ba4-bddc-4981-b21b-705355c325fe" src="/sites/default/files/inline-images/guerbet.png" class="align-center" /> <p> </p> <p><strong>Villepinte (France), February 19, 2020 — </strong>Guerbet, the global specialist in contrast media and solutions for diagnostic and interventional imaging, will attend ECR (European Congress of Radiology) 2020, from March 11<sup>th</sup> to 15<sup>th</sup> in Vienna (Austria). This year, healthcare professionals will be able to experience the Group's latest innovations, its patient pathway and its comprehensive educational program, at the Tech Gate Building near the Austria Center Vienna.</p> </div> </div> <div class="row p-relative"> <div class="col-xs-12 col-sm-12 col-md-12"> <div> <i class="rectangle"> <a href="https://www.myesr.org/sites/default/files/styles/original_image/public/2020-02/guerbet_at_ECR2020.png?itok=zH_ZBgo7" title="" class="square magnific-popup-image"> <article class="media media-medium-image view-mode-image-rectangle"> <picture> <!--[if IE 9]><video style="display: none;"><![endif]--> <source srcset="/sites/default/files/styles/rectangle_medium/public/2020-02/guerbet_at_ECR2020.png?itok=T3dE8oyq 1x" media="all and (min-width: 1200px)" type="image/png"/> <source srcset="/sites/default/files/styles/rectangle_medium/public/2020-02/guerbet_at_ECR2020.png?itok=T3dE8oyq 1x" media="all and (max-width: 1199px)" type="image/png"/> <source srcset="/sites/default/files/styles/rectangle_medium/public/2020-02/guerbet_at_ECR2020.png?itok=T3dE8oyq 1x" media="all and (min-width: 992px)" type="image/png"/> <source srcset="/sites/default/files/styles/rectangle_medium/public/2020-02/guerbet_at_ECR2020.png?itok=T3dE8oyq 1x" media="all and (max-width: 991px)" type="image/png"/> <source srcset="/sites/default/files/styles/rectangle_medium/public/2020-02/guerbet_at_ECR2020.png?itok=T3dE8oyq 1x" media="all and (min-width: 768px)" type="image/png"/> <source srcset="/sites/default/files/styles/rectangle_medium/public/2020-02/guerbet_at_ECR2020.png?itok=T3dE8oyq 1x" media="all and (max-width: 767px)" type="image/png"/> <!--[if IE 9]></video><![endif]--> <img src="/sites/default/files/styles/rectangle_medium/public/2020-02/guerbet_at_ECR2020.png?itok=T3dE8oyq" typeof="foaf:Image" class="img-responsive" /> </picture> </article> </a> </i> </div> </div> </div> <div class="row p-relative"> <div class="col-xs-12 col-sm-12 col-md-12"> <h5>Women’s Health and Augmented Intelligence in focus </h5> <p>This immersion will begin with the discovery of two new areas dedicated to Augmented Intelligence and Women's Health.</p> <p>On this occasion, Guerbet reaffirms its ambition to extend its portfolio of digital AI solutions with the launch of icobrain<sup>®</sup>. Demos will be performed on this Saas (Software as a Service) artificial intelligence-based medical imaging solution, designed to help radiologists and neurologists diagnose and monitor patients with neurological disorders. </p> <p>The Women’s Health space will be the opportunity to learn more about the use of Lipiodol<sup>®</sup> Ultra Fluid for Hysterosalpingography within infertility management and Patent Blue V for sentinel node identification before biopsy in patients with operable breast cancer.<br />  </p> <h5>A Patient Pathway to practice on Guerbet’s solutions</h5> <p>In addition to this focus, Guerbet will exhibit its current range of contrast media, injections systems, medical devices and digital solutions for CT, MR, Cath Lab and interventional radiology. Throughout a patient pathway, visitors will interact with many demonstrations to discover our solutions.<br />  </p> <h5>A comprehensive educational program with 16 courses and 2 symposia  </h5> <p>From Wednesday to Friday, Guerbet will be launching a new and unique program called “On the Pathway to Knowledge”. This shall give the opportunity to radiologists, residents, radiographers, scientists involved in routine or research medical imaging the chance to improve their knowledge in various areas of interest, such as Artificial Intelligence, emerging radiological techniques, safety and innovation in contrast agents. The audience will meet international experts, key opinion leaders and pioneers in different fields.<br />  </p> <p>The two Guerbet symposia will focus on:</p> <p><strong><em>“Challenges and pitfalls of current clinical practice: where will Augmented Intelligence bring value?”</em></strong></p> <ul> <li>Thursday, March 12 at 12:45pm</li> <li>Auditorium at Tech Gate</li> </ul> <p><strong><em>“Challenge Your Expertise in GI (gastro-intestinal) Advanced Clinical Cases”</em></strong></p> <ul> <li>Friday, March 13 at 12:45pm</li> <li>Auditorium at Tech Gate<br />  </li> </ul> <h5>Two communications about gadopiclenol</h5> <p>The results from two clinical studies on gadopiclenol, Guerbet’s new macrocyclic gadolinium-based contrast agent in development, will be presented during the ECR scientific sessions:</p> <p><strong><em>“Impact of the novel contrast agent gadopiclenol on decision making in patients with brain metastases” </em></strong></p> <ul> <li>Oral presentation in session “Gadolinium retention and neurovascular imaging”</li> <li>Wednesday, March 11 at 2pm</li> </ul> <p><strong><em>“Pharmacokinetics and safety of gadopiclenol in healthy volunteers and in patients with impaired renal function” </em></strong></p> <ul> <li>ePoster in The Voice of EPOS session</li> <li>Thursday, March 12 at 9am</li> </ul> <p class="text-xs-center"> <a class="btn btn-lg btn-icon" href="https://www.guerbet.com/ecr-2020/" target="_blank" > <i class="pe-7s-link"></i> Learn more </a> </p> </div> </div> <div class="row p-relative"> <div class="col-xs-12 col-sm-12 col-md-12"> <h5><br /> About Guerbet</h5> <p>Guerbet is a pioneer in the contrast-agent field, with more than 90 years' experience, and is a leader in medical imaging worldwide. It offers a comprehensive range of pharmaceutical products, medical devices and services for diagnostic and interventional imaging, to improve the diagnosis and treatment of patients. With 8% of revenue dedicated to R&amp;D, Guerbet is a substantial investor in research and innovation. Guerbet (GBT) is listed on Euronext Paris (segment B – mid caps) and generated €790 million in revenue in 2018. For more information about Guerbet, please visit <a href="www.guerbet.com" target="_blank">www.guerbet.com</a>.</p> <p> <strong> </strong></p> <p><strong>Contacts</strong><strong><em> </em></strong></p> </div> </div> <div class="row p-relative"> <div class="col-xs-12 col-sm-12 col-md-6"> <p><strong><em>Guerbet</em></strong><br /> <strong>Anne-Laure Delasalle</strong><br /> <strong>Communications Director</strong><br /> + 33 (0)1 45 91 50 03<br /> <a href="mailto:anne-laure.delasalle@guerbet.com">anne-laure.delasalle@guerbet.com</a></p> </div> <div class="col-xs-12 col-sm-12 col-md-6"> <p><strong><em>Media Relations</em></strong><br /> <strong>Alize RP</strong><br /> <strong>Caroline Carmagnol</strong><br /> +33 (0)6 64 18 99 59<br /> <a href="mailto:guerbet@alizerp.com">guerbet@alizerp.com</a></p> </div> </div> <i class="banner-image force-fullsize"> <picture> <!--[if IE 9]><video style="display: none;"><![endif]--> <source srcset="/sites/default/files/styles/header_sm_min_width_1200px/public/2018-06/MYESR_PageBanner6_web.jpg?itok=oiMSj_3M 1x" media="all and (min-width: 1200px)" type="image/jpeg"/> <source srcset="/sites/default/files/styles/header_sm_max_width_1199px/public/2018-06/MYESR_PageBanner6_web.jpg?itok=9DrsuzsI 1x" media="all and (max-width: 1199px)" type="image/jpeg"/> <source srcset="/sites/default/files/styles/header_sm_max_width_1199px/public/2018-06/MYESR_PageBanner6_web.jpg?itok=9DrsuzsI 1x" media="all and (min-width: 992px)" type="image/jpeg"/> <source srcset="/sites/default/files/styles/header_sm_max_width_991px/public/2018-06/MYESR_PageBanner6_web.jpg?itok=sKnv3ZpR 1x" media="all and (max-width: 991px)" type="image/jpeg"/> <source srcset="/sites/default/files/styles/header_sm_max_width_991px/public/2018-06/MYESR_PageBanner6_web.jpg?itok=sKnv3ZpR 1x" media="all and (min-width: 768px)" type="image/jpeg"/> <source srcset="/sites/default/files/styles/header_sm_max_width_767px/public/2018-06/MYESR_PageBanner6_web.jpg?itok=mDUCNuR1 1x" media="all and (max-width: 767px)" type="image/jpeg"/> <!--[if IE 9]></video><![endif]--> <img src="/sites/default/files/styles/header_sm_max_width_767px/public/2018-06/MYESR_PageBanner6_web.jpg?itok=mDUCNuR1" alt="MYESR_PageBanner6_web.jpg" typeof="foaf:Image" class="img-responsive" /> </picture> </i> <span class="a2a_kit a2a_kit_size_32 addtoany_list" data-a2a-url="https://www.myesr.org/article/3179" data-a2a-title="Guerbet offers a unique experience at Tech Gate during ECR 2020"><a class="a2a_button_facebook"></a><a class="a2a_button_twitter"></a></span> Mon, 17 Feb 2020 19:00:55 +0000 myESR 3179 at https://www.myesr.org European Radiology and Respiratory Societies team up to promote organised lung cancer screening in Europe https://www.myesr.org/article/3175 <span property="schema:name">European Radiology and Respiratory Societies team up to promote organised lung cancer screening in Europe</span> <span rel="schema:author"><span title="View user profile." href="/user/67" lang="" about="/user/67" typeof="schema:Person" property="schema:name" datatype="">moderator_David</span> </span> <span property="schema:dateCreated" content="2020-02-12T15:00:27+00:00">Wed, 02/12/2020 - 16:00</span> <div class="row p-relative"> <div class="col-xs-12 col-sm-12 col-md-12"> <p><span><span><span><strong>February 2020 - The European Society of Radiology (ESR) is pleased to announce the publication of an important joint statement with the European Respiratory Society (ERS) on lung cancer screening (LCS) in Europe. Endorsed by both societies, the paper contains a contemporary, non-systematic review of the literature and common practice in lung cancer screening in Europe and also refers to the important NELSON study results. </strong></span></span></span></p> <p><span><span><span>Intended to be an update of a past ESR-ERS working group white paper on lung cancer screening, published in 2015, the statement was published simultaneously in <em>European Radiology</em> and the <em>European Respiratory Journal</em>. Focussing on new findings and current discussions surrounding screening programmes, it reviews the evidence from LCS trials, offering a description of the current practice of LCS, as well as aspects that have not received adequate attention until now. Both the ESR and ERS anticipate that the publication of the paper will stimulate further discussion and action on the implementation of lung cancer screening programmes in European countries.</span></span></span></p> <p><span><span><span>The ESR and ERS agree that Europe’s health systems need to adapt to allow citizens to benefit from organised pathways, rather than unsupervised initiatives, to allow early diagnosis of lung cancer and reduce the mortality rate. The authors argue that now is the time to set up and conduct demonstration programmes focusing, among other points, on methodology, standardisation, tobacco cessation, education on healthy lifestyle, cost-effectiveness and a central registry.</span></span></span></p> <p><span><span><span>The paper was written by members of the ESR-ERS Working Group who have been collaborating on the statement since early 2018. Chaired by Prof. Hans-Ulrich Kauczor, of the University Hospital Heidelberg, Germany, and the German Centre of Lung Research, the group consists of 22 representatives from the ESR and ERS including radiologists, pulmonologists, thoracic oncologists, thoracic surgeons, psychologists, epidemiologist, molecular biologists, health care managers and patients. In addition, members of the Patient Advisory Committee of the European Lung Foundation (ELF), also offered their voices to provide the relevant and unique patient perspective on screening programmes in Europe. </span></span></span></p> <p><span><span><span>On publication of the joint statement, Prof. Kauczor stated, ‘All stakeholders involved are convinced that patients and citizens will benefit largely from early diagnosis of lung cancer and that screening will reduce significantly the mortality of the number 1 killer worldwide - cancer. We emphasise the importance of advocacy by major European and national medical societies and patient organisations to broadly raise public awareness’.</span></span></span></p> <p><span><span><span>The publication of the paper is another crucial milestone, following a joint event organised by ESR, ERS and Lung Cancer Europe (LuCE) at the European Parliament in November 2019, on the occasion of which a <a href="https://www.myesr.org/media/5126"><u>factsheet</u></a> on lung cancer was launched, calling for an update of the 2003 European Council Recommendation on cancer screening, and for Member States to exchange best practices and gradually implement lung cancer screening programmes while upholding the highest standards of care and patient safety. More information about the event can be found <u><a href="https://www.myesr.org/article/2598">here</a></u>.</span></span></span></p> <p><span><span><span>To read the paper in <em>European Radiology </em>click <u><a href="https://link.springer.com/article/10.1007/s00330-020-06727-7" target="_blank">here</a></u>.<br /> To read the paper in the <em>European Respiratory Journal</em> click <u><a href="https://erj.ersjournals.com/content/55/2/1900506" target="_blank">here</a></u>.</span></span></span></p> </div> </div> <i class="banner-image force-fullsize"> <picture> <!--[if IE 9]><video style="display: none;"><![endif]--> <source srcset="/sites/default/files/styles/header_sm_min_width_1200px/public/2018-06/MYESR_PageBanner6_web.jpg?itok=oiMSj_3M 1x" media="all and (min-width: 1200px)" type="image/jpeg"/> <source srcset="/sites/default/files/styles/header_sm_max_width_1199px/public/2018-06/MYESR_PageBanner6_web.jpg?itok=9DrsuzsI 1x" media="all and (max-width: 1199px)" type="image/jpeg"/> <source srcset="/sites/default/files/styles/header_sm_max_width_1199px/public/2018-06/MYESR_PageBanner6_web.jpg?itok=9DrsuzsI 1x" media="all and (min-width: 992px)" type="image/jpeg"/> <source srcset="/sites/default/files/styles/header_sm_max_width_991px/public/2018-06/MYESR_PageBanner6_web.jpg?itok=sKnv3ZpR 1x" media="all and (max-width: 991px)" type="image/jpeg"/> <source srcset="/sites/default/files/styles/header_sm_max_width_991px/public/2018-06/MYESR_PageBanner6_web.jpg?itok=sKnv3ZpR 1x" media="all and (min-width: 768px)" type="image/jpeg"/> <source srcset="/sites/default/files/styles/header_sm_max_width_767px/public/2018-06/MYESR_PageBanner6_web.jpg?itok=mDUCNuR1 1x" media="all and (max-width: 767px)" type="image/jpeg"/> <!--[if IE 9]></video><![endif]--> <img src="/sites/default/files/styles/header_sm_max_width_767px/public/2018-06/MYESR_PageBanner6_web.jpg?itok=mDUCNuR1" alt="MYESR_PageBanner6_web.jpg" typeof="foaf:Image" class="img-responsive" /> </picture> </i> <span class="a2a_kit a2a_kit_size_32 addtoany_list" data-a2a-url="https://www.myesr.org/article/3175" data-a2a-title="European Radiology and Respiratory Societies team up to promote organised lung cancer screening in Europe"><a class="a2a_button_facebook"></a><a class="a2a_button_twitter"></a></span> Wed, 12 Feb 2020 15:00:27 +0000 moderator_David 3175 at https://www.myesr.org European Congress of Radiology first major congress to hold dedicated trending topic session on novel coronavirus https://www.myesr.org/article/3173 <span property="schema:name">European Congress of Radiology first major congress to hold dedicated trending topic session on novel coronavirus</span> <span rel="schema:author"><span title="View user profile." href="/user/67" lang="" about="/user/67" typeof="schema:Person" property="schema:name" datatype="">moderator_David</span> </span> <span property="schema:dateCreated" content="2020-02-12T13:53:48+00:00">Wed, 02/12/2020 - 14:53</span> <div class="row p-relative"> <div class="col-xs-12 col-sm-12 col-md-12"> <p><span><span><span><strong><span lang="EN-GB" xml:lang="EN-GB"><span>Addressing the ongoing developments and challenges for public health related to the 2019 novel coronavirus disease (COVID-19), the European Society of Radiology (ESR) will hold a special ‘trending topic session’ at the European Congress of Radiology (ECR) 2020. The session will feature first-hand experts, and will be publicly available on-site and online.  </span></span></strong></span></span></span></p> <p><span><span><span><span lang="EN-GB" xml:lang="EN-GB"><span>The trending topic session will feature experts from Wuhan, Paris, Frankfurt, Munich and Rome, who have first-hand experience in imaging and treating patients infected with COVID-19 sharing their experience with the audience. The podium not only includes radiologists, but also pulmonologists, epidemiologists, and virologists underlining the need for interdisciplinary work to fight this new disease.  </span></span></span></span></span></p> <p><span><span><span><span lang="EN-US" xml:lang="EN-US"><span>Given the ongoing and rapid developments, the final session programme is still a work in progress, but will highlight the different challenges that health care providers are facing at present. This includes imaging specificities in patients in acute and follow-up stages of COVID-19 pneumonia, virologic and diagnostic aspects, how previous outbreaks of similar viruses have influenced the current treatment and imaging strategies, as well as the difficulties for the professionals and public health management in the epicenter of the current outbreak.</span></span></span></span></span></p> <p><span><span><span><span lang="EN-GB" xml:lang="EN-GB"><span>Due to this exclusive programme outline, the coronavirus session is expected to be a highly popular and insightful event. In keeping with its commitment to bring the latest scientific developments to its members and the public, the ESR will grant free onsite access to the session in Vienna (no ECR registration required), and in addition will broadcast this session live via <a href="https://connect.myesr.org/package/ecr2020/" target="_blank">ESR Connect</a> free of charge. </span></span></span></span></span></p> <p><span><span><span><span lang="EN-GB" xml:lang="EN-GB"><span>The full coronavirus session programme will be available shortly on <a href="https://connect.myesr.org/package/ecr2020/" target="_blank">ESR Connect</a>. </span></span></span></span></span></p> <p><span><span><span><strong><span lang="EN-GB" xml:lang="EN-GB"><span>Present from home made possible</span></span></strong></span></span></span></p> <p><span><span><span><span lang="EN-GB" xml:lang="EN-GB"><span>Due to the fact that many radiologists and medical professionals from China and other concerned areas are required to stay at their hospitals to diagnose and treat patients, the ESR is once again living up to its reputation as the most fast-thinking and highly-adaptable society.</span></span></span></span></span></p> <p><span><span><span><span lang="EN-GB" xml:lang="EN-GB"><span>With ‘Present from home’, the ESR is enabling speakers affected by the COVID-19 outbreak to present their ECR 2020 lectures via live streaming remotely from their homes or hospitals abroad. All technical arrangements for this highly innovative endeavour have already been completed in record time and ECR is fully set to feature lectures streamed from abroad. The option to present from home will ensure that these professionals are still able to showcase their work and remain a part of the premiere congress in medical imaging. </span></span></span></span></span></p> <p><span><span><span><span lang="EN-GB" xml:lang="EN-GB"><span>It is the ESR’s endeavour to overcome any obstacles that would hinder colleagues from anywhere in the world being able to share their expertise and to ensure that ECR remains diverse and united for the global radiological community. </span></span></span></span></span></p> </div> </div> <i class="banner-image force-fullsize"> <picture> <!--[if IE 9]><video style="display: none;"><![endif]--> <source srcset="/sites/default/files/styles/header_sm_min_width_1200px/public/2018-06/MYESR_PageBanner6_web.jpg?itok=oiMSj_3M 1x" media="all and (min-width: 1200px)" type="image/jpeg"/> <source srcset="/sites/default/files/styles/header_sm_max_width_1199px/public/2018-06/MYESR_PageBanner6_web.jpg?itok=9DrsuzsI 1x" media="all and (max-width: 1199px)" type="image/jpeg"/> <source srcset="/sites/default/files/styles/header_sm_max_width_1199px/public/2018-06/MYESR_PageBanner6_web.jpg?itok=9DrsuzsI 1x" media="all and (min-width: 992px)" type="image/jpeg"/> <source srcset="/sites/default/files/styles/header_sm_max_width_991px/public/2018-06/MYESR_PageBanner6_web.jpg?itok=sKnv3ZpR 1x" media="all and (max-width: 991px)" type="image/jpeg"/> <source srcset="/sites/default/files/styles/header_sm_max_width_991px/public/2018-06/MYESR_PageBanner6_web.jpg?itok=sKnv3ZpR 1x" media="all and (min-width: 768px)" type="image/jpeg"/> <source srcset="/sites/default/files/styles/header_sm_max_width_767px/public/2018-06/MYESR_PageBanner6_web.jpg?itok=mDUCNuR1 1x" media="all and (max-width: 767px)" type="image/jpeg"/> <!--[if IE 9]></video><![endif]--> <img src="/sites/default/files/styles/header_sm_max_width_767px/public/2018-06/MYESR_PageBanner6_web.jpg?itok=mDUCNuR1" alt="MYESR_PageBanner6_web.jpg" typeof="foaf:Image" class="img-responsive" /> </picture> </i> <span class="a2a_kit a2a_kit_size_32 addtoany_list" data-a2a-url="https://www.myesr.org/article/3173" data-a2a-title="European Congress of Radiology first major congress to hold dedicated trending topic session on novel coronavirus"><a class="a2a_button_facebook"></a><a class="a2a_button_twitter"></a></span> Wed, 12 Feb 2020 13:53:48 +0000 moderator_David 3173 at https://www.myesr.org The ESR raises its voice on AI and digital health in Brussels https://www.myesr.org/article/2620 <span property="schema:name">The ESR raises its voice on AI and digital health in Brussels</span> <span rel="schema:author"><span title="View user profile." href="/user/1" lang="" about="/user/1" typeof="schema:Person" property="schema:name" datatype="">myESR</span> </span> <span property="schema:dateCreated" content="2019-12-20T10:53:33+00:00">Fri, 12/20/2019 - 11:53</span> <div class="row p-relative"> <div class="col-xs-12 col-sm-12 col-md-12"> <p>The European Society of Radiology (ESR), represented by its President, Prof. Boris Brkljacic, participated in a series of successful meetings and events on the 10<sup>th</sup> of December in Brussels to strengthen the position of medical imaging on the European Union (EU) health policy agenda.</p> <p>In the afternoon, the ESR participated in the event entitled “Europe’s Beating Cancer Plan – Better access to cancer care in Europe?” hosted by EU40, a group of young Members of the European Parliament under the age of 40. During the Q&amp;A session, Prof. Brkljacic intervened by highlighting the contribution of radiology towards accurate diagnosis and treatment. Furthermore, he called on the EU institutions to act and to gradually implement lung cancer screening programmes following successful clinical trials that have demonstrated their effectiveness on the overall mortality rate.</p> <img alt="EU 40" data-entity-type="file" data-entity-uuid="d11a6469-46ed-4c38-a9d3-aaa571c3616c" height="351" src="/sites/default/files/inline-images/EU40.png" width="264" class="align-center" /> <p><br /> In an interview with EurActiv, Prof. Brkljacic provided the society’s perspective on the digital transformation of healthcare and the uptake of Artificial Intelligence (AI) both in clinical practice and research. It was emphasised that imaging technologies were far ahead from other specialties in embracing AI, with the potential to generate rapid diagnoses as well as targeted and personalised treatments. Despite the potential for transforming healthcare systems, Prof. Brkljacic drew attention to ethical and privacy issues, which require for AI to be introduced alongside a clear framework guiding its development and use.</p> </div> </div> <div class="row p-relative"> <div class="col-xs-12 col-sm-12 col-md-12"> <img alt="in an interview with EurActiv" data-entity-type="file" data-entity-uuid="d79ae7b4-3c29-4d5c-8bba-062fe5fd1137" height="267" src="/sites/default/files/inline-images/ESRraisesvoice2.png" width="355" class="align-center" /> <p><br /> In the evening, Prof. Brkljacic gave a voice to the medical profession’s views on digital health at the event "Digital Transformation of Healthcare - Unlocking the potential of digital solutions for patients, healthcare providers and health systems", kindly hosted by GE Healthcare and the European Brain Council (EBC). The meeting brought together a panel of experts to discuss pressing issues on the path towards the digitisation of healthcare systems across Europe. Prof. Brkljacic underlined the radiology profession’s support for breakthrough innovation, which should be integrated into healthcare hand-in-hand with ethical and privacy standards, putting the patients’ interests first. <br /> <br /> The productive day illustrated once again that the ESR is ready to constructively engage with the EU institutions, industry, patients and any other stakeholders to harness the potential of digital solutions and Artificial Intelligence in healthcare for patient-centred outcomes and personalised care.<br /> <br /> Please read here the <a href="https://www.euractiv.com/section/health-consumers/news/health-professor-ai-has-huge-potential-provided-ethical-issues-can-be-solved/">EurActiv interview</a> with ESR President Prof. Brkljacic and another <a href="https://www.euractiv.com/section/health-consumers/news/clear-standards-required-for-development-and-use-of-ai-in-healthcare/">EurActiv article</a> in which Prof. Brkljacic is featured.</p> <p> </p> </div> </div> <i class="banner-image force-fullsize"> <picture> <!--[if IE 9]><video style="display: none;"><![endif]--> <source srcset="/sites/default/files/styles/header_sm_min_width_1200px/public/2018-06/MYESR_PageBanner6_web.jpg?itok=oiMSj_3M 1x" media="all and (min-width: 1200px)" type="image/jpeg"/> <source srcset="/sites/default/files/styles/header_sm_max_width_1199px/public/2018-06/MYESR_PageBanner6_web.jpg?itok=9DrsuzsI 1x" media="all and (max-width: 1199px)" type="image/jpeg"/> <source srcset="/sites/default/files/styles/header_sm_max_width_1199px/public/2018-06/MYESR_PageBanner6_web.jpg?itok=9DrsuzsI 1x" media="all and (min-width: 992px)" type="image/jpeg"/> <source srcset="/sites/default/files/styles/header_sm_max_width_991px/public/2018-06/MYESR_PageBanner6_web.jpg?itok=sKnv3ZpR 1x" media="all and (max-width: 991px)" type="image/jpeg"/> <source srcset="/sites/default/files/styles/header_sm_max_width_991px/public/2018-06/MYESR_PageBanner6_web.jpg?itok=sKnv3ZpR 1x" media="all and (min-width: 768px)" type="image/jpeg"/> <source srcset="/sites/default/files/styles/header_sm_max_width_767px/public/2018-06/MYESR_PageBanner6_web.jpg?itok=mDUCNuR1 1x" media="all and (max-width: 767px)" type="image/jpeg"/> <!--[if IE 9]></video><![endif]--> <img src="/sites/default/files/styles/header_sm_max_width_767px/public/2018-06/MYESR_PageBanner6_web.jpg?itok=mDUCNuR1" alt="MYESR_PageBanner6_web.jpg" typeof="foaf:Image" class="img-responsive" /> </picture> </i> <span class="a2a_kit a2a_kit_size_32 addtoany_list" data-a2a-url="https://www.myesr.org/article/2620" data-a2a-title="The ESR raises its voice on AI and digital health in Brussels"><a class="a2a_button_facebook"></a><a class="a2a_button_twitter"></a></span> Fri, 20 Dec 2019 10:53:33 +0000 myESR 2620 at https://www.myesr.org Women in Radiology: Gender diversity is not a metric – it is a tool for excellence https://www.myesr.org/article/2616 <span property="schema:name">Women in Radiology: Gender diversity is not a metric – it is a tool for excellence</span> <span rel="schema:author"><span title="View user profile." href="/user/1" lang="" about="/user/1" typeof="schema:Person" property="schema:name" datatype="">myESR</span> </span> <span property="schema:dateCreated" content="2019-12-04T17:32:53+00:00">Wed, 12/04/2019 - 18:32</span> <div class="row p-relative"> <div class="col-xs-12 col-sm-12 col-md-12"> <p><strong>December 2019 - A group of prominent European and North American members of the radiological community have collaborated to produce an important publication on the status of women in the field of radiology, highlighting positive developments as well as areas where greater progress is needed. </strong></p> <p>Published in <em>European Radiology</em>, the special report, <a href="https://link.springer.com/article/10.1007/s00330-019-06493-1" target="_blank">‘Women in Radiology: Gender diversity is not a metric – it is a tool for excellence’</a>, reviews the current state of gender diversity in academic and leadership positions in radiology internationally, exploring a wide range of potential reasons for gender disparities, including the lack of role models and mentorship, unconscious bias, and generational changes in attitudes about the desirability of leadership positions. The report also offers strategies to proactively increase the representation of women in academic and leadership positions. Contributing authors to the paper include Prof. Rahel Kubik-Huch, Prof. Valérie Vilgrain, Prof. Gabriel Krestin, Prof. Maximillian Reiser, Prof. Ulrike Attenberger, Prof. Christopher Hess and Prof. Hedvig Hricak.</p> <p>The publication of this special report is intended as a follow-up to the unique <a href="https://www.myesr.org/women-in-focus">‘Women in Focus’ programme</a>, which was held at this year’s <a href="https://www.myesr.org/congress">European Congress of Radiology (ECR)</a> in Vienna. The event, which was chaired by Prof. Hricak in coordination with the <a href="https://www.myesr.org">European Society of Radiology</a>, saw a range of diverse speakers discussing issues of particular concern for women working in the medical field. It included audience participation and touched on important issues for young professionals such as leadership, mentoring, and facing challenging environments. To read more about ‘Women in Focus’ and to view all the highlights, click <a href="https://www.myesr.org/women-in-focus">here</a>.</p> <p>Prof. Hricak, who is Chairman of the Department of Radiology at Memorial Sloan Kettering Cancer Center, New York, highlights that the need to address issues of gender balance and diversity is more important than ever. ‘Today, workforce diversity is acknowledged as an essential tool to better adapt to the needs of our complex environment,’ she said. ‘Research in multiple industries has shown that including people of diverse genders, races, cultural backgrounds, skill sets, and viewpoints results in increased workforce engagement and enhanced critical decision-making. This fosters greater innovation and patient satisfaction - proving that diversity should be seen not as a mere addendum to a job announcement, but as the heart and soul of a successful workforce.’</p> <p>Prof. Kubik, who is Chairman of the Department of Radiology at Kantonsspital Baden, Switzerland, added. ‘It is important to realise that gender diversity and equality is not just a women’s issue. It is about shaping our future together – in radiology, in leadership and as a society.’</p> <p>In addition to the special report in <em>European Radiology</em>, the ‘Women in Focus’ programme inspired a publication entitled, <a href="https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(19)30263-3/fulltext" target="_blank">‘Safe spaces for women in challenging environments’</a>. This editorial comment, which was published in <em>The Lancet Global Health</em> in August, focusses on the millions of women worldwide who struggle for basic human rights every day. It encourages all women to support each other across the boundaries of race, culture, and tradition.</p> </div> </div> <i class="banner-image force-fullsize"> <picture> <!--[if IE 9]><video style="display: none;"><![endif]--> <source srcset="/sites/default/files/styles/header_sm_min_width_1200px/public/2018-06/MYESR_PageBanner6_web.jpg?itok=oiMSj_3M 1x" media="all and (min-width: 1200px)" type="image/jpeg"/> <source srcset="/sites/default/files/styles/header_sm_max_width_1199px/public/2018-06/MYESR_PageBanner6_web.jpg?itok=9DrsuzsI 1x" media="all and (max-width: 1199px)" type="image/jpeg"/> <source srcset="/sites/default/files/styles/header_sm_max_width_1199px/public/2018-06/MYESR_PageBanner6_web.jpg?itok=9DrsuzsI 1x" media="all and (min-width: 992px)" type="image/jpeg"/> <source srcset="/sites/default/files/styles/header_sm_max_width_991px/public/2018-06/MYESR_PageBanner6_web.jpg?itok=sKnv3ZpR 1x" media="all and (max-width: 991px)" type="image/jpeg"/> <source srcset="/sites/default/files/styles/header_sm_max_width_991px/public/2018-06/MYESR_PageBanner6_web.jpg?itok=sKnv3ZpR 1x" media="all and (min-width: 768px)" type="image/jpeg"/> <source srcset="/sites/default/files/styles/header_sm_max_width_767px/public/2018-06/MYESR_PageBanner6_web.jpg?itok=mDUCNuR1 1x" media="all and (max-width: 767px)" type="image/jpeg"/> <!--[if IE 9]></video><![endif]--> <img src="/sites/default/files/styles/header_sm_max_width_767px/public/2018-06/MYESR_PageBanner6_web.jpg?itok=mDUCNuR1" alt="MYESR_PageBanner6_web.jpg" typeof="foaf:Image" class="img-responsive" /> </picture> </i> <span class="a2a_kit a2a_kit_size_32 addtoany_list" data-a2a-url="https://www.myesr.org/article/2616" data-a2a-title="Women in Radiology: Gender diversity is not a metric – it is a tool for excellence"><a class="a2a_button_facebook"></a><a class="a2a_button_twitter"></a></span> Wed, 04 Dec 2019 17:32:53 +0000 myESR 2616 at https://www.myesr.org Results of a major breast cancer imaging trial presented at ECR 2019 published in The New England Journal of Medicine https://www.myesr.org/article/2610 <span property="schema:name">Results of a major breast cancer imaging trial presented at ECR 2019 published in The New England Journal of Medicine</span> <span rel="schema:author"><span title="View user profile." href="/user/1" lang="" about="/user/1" typeof="schema:Person" property="schema:name" datatype="">myESR</span> </span> <span property="schema:dateCreated" content="2019-11-27T15:01:47+00:00">Wed, 11/27/2019 - 16:01</span> <div class="row p-relative"> <div class="col-xs-12 col-sm-12 col-md-12"> <p></p> <p><strong>Thursday, November 28, 2019 - The outcomes of the multicentre DENSE trial on breast cancer, which was conducted in The Netherlands and first presented at the </strong><a href="https://www.myesr.org/congress"><strong>European Congress of Radiology (ECR)</strong></a><strong> 2019, has now been published in <a href="https://www.nejm.org/doi/full/10.1056/NEJMoa1903986"><em>The New England Journal of Medicine</em></a>. Presented by Prof. Carla H. van Gils at an ECR </strong><a href="https://www.myesr.org/congress/scientific-programme#paragraph_grid_17169"><strong>Clinical Trials in Radiology (CTiR)</strong></a><strong> session, the results provide practical insights into the use of supplemental magnetic resonance imaging (MRI) in screening for breast cancer, and further strengthen the ECR’s reputation as the No.1 meeting point for groundbreaking imaging innovation and cutting-edge radiology research from across the globe.  </strong></p> <p> ‘This is an exciting trial led by Professor Carla van Gils and we were happy to have her present it as a landmark clinical trial during a CTiR session at ECR 2019’, said Professor Marc Dewey, Chairperson of the ECR Programme Planning Committee’s Scientific Paper Subcommittee. ‘I would like to wholeheartedly congratulate Carla and her team for having accomplished this impressive analysis of interval cancer in a large multicenter randomized trial answering pivotal questions about the clinical effectiveness of supplemental MRI screening for women with extremely dense breast tissue.’</p> <p>Titled, ‘Supplemental MRI Screening for Women with Extremely Dense Breast Tissue’, the publication describes the first results of the DENSE trial which involved 40,373 women between the ages of 50 and 75 years with extremely dense breast tissue and normal results from a mammography screening. These women were divided into two groups, those who were invited for supplemental MRI screening (8061 women), and those who received only a mammography screening (control group 32,312 women). </p> <p>The primary outcome of the DENSE trial, according to its protocol, is the number of interval cancers in the MRI group compared to the control group after three screening rounds, i.e. six years. Today’s publication of the DENSE trial in the NEJM represents the first interim analysis of this primary outcome after the first screening round. The study investigators showed that supplemental MRI screening reduced the interval-cancer rate from 5.0 per 1000 screenings in the control group to 2.5 per 1000 screenings in the MRI-invitation group. This reduced the interval-cancer rate in the supplemental MRI group by 1.3 per 1000 person-years. Importantly, the false positive rate of MRI was 8.0% (79.8 per 1000 screenings) and only 26.3% of patients who had a breast biopsy following MRI actually had breast cancer. Overall mortality is not a pre-specified outcome of the trial and was similar in the two groups after two years of follow-up (65 of 8061 patients in the supplemental MRI group and 236 of 32,312 patients in the mammography control group).</p> <p>Informed consent for participation was only requested from women assigned to the MRI group in order to avoid anxiety and limit cross-over to MRI in the control group. Data on the primary outcome of interval cancer in the two groups was retrieved from the Netherlands Cancer Registry. Only 4783 of the 8061 patients (59.3%) invited to supplemental MRI screening actually underwent MRI, mostly due to MRI-related inconveniences and anxiety regarding the result according to an earlier report of the group in 2018.* Moreover, women with higher socio-economic status participated in the MRI screening more often than women with lower status. According to the intention-to-treat design however, all patients invited for MRI screening were included in the intervention group. In comparison with the control group, MRI screening halved the rate of interval breast cancer. When only the MRI participants were considered, the interval-cancer rate was further reduced to 0.8 per 1000 screenings further supporting the need to reduce MRI-related inconveniences, for instance, by abbreviated protocols.**</p> <p>In the accompanying editorial, Deputy Editor of the journal, Dan. L. Longo, highlights the importance of the paper, and calls for research to be extended to determine if the use of MRI screening for women with dense beast tissue can improve survival rates. ‘The findings of Bakker et al. are important, since they provide high-quality data from a randomized trial where none existed.’ He goes on to conclude that, ‘the findings of this trial are likely to reinforce the idea that MRI screening is important in women with dense breast tissue. But will we be putting these women at increased risk of procedures without contributing to their eventual survival?’ </p> <p>Professor Dewey concluded that, ‘It will be of great interest to see the results of the DENSE trial following the second and third screening round to further inform the radiology community about the risks and benefits of supplemental MRI screening in women with extremely dense breast tissue.’</p> <p>Clinical Trials in Radiology sessions will return at ECR 2020 and will take place in Room Y from March 11-13 every day at 2 PM until 3:30 PM. The CTiR sessions will cover results from the second screening round of the DENSE trial and 17 further trials about imaging of prostate cancer, pancreatic cancer, breast cancer, Hodgkin lymphoma, as well as the topics of artificial intelligence, radiation safety, pulmonary embolism, stroke and interventional radiology.</p> <p>You can register for the congress <a href="https://www.myesr.org/registration">now</a> for a special reduced fee, available for all those who register before December 12.</p> <p>* <a href="https://www.ncbi.nlm.nih.gov/pubmed/29759590">https://www.ncbi.nlm.nih.gov/pubmed/29759590</a><br /> ** <a href="https://www.ncbi.nlm.nih.gov/pubmed/30691370">https://www.ncbi.nlm.nih.gov/pubmed/30691370</a></p> <p><br /> <img alt="van Gils" data-entity-type="file" data-entity-uuid="0582cbf1-69b4-40fb-b7b3-92aa740f6b3d" src="/sites/default/files/inline-images/vanGils.png" /></p> <p>Professor Carla H. van Gils, who presented at the ECR 2019 CTiR session<br /> © UMC Utrecht</p> <p>--------------------------------------------------------------------------------------------------------------------------------------</p> <p>The DENSE trial is published in the NEJM and can be accessed <a href="https://www.nejm.org/doi/full/10.1056/NEJMoa1903986">here</a>.</p> <p>The full citation of the report is: Bakker MF, de Lange SV, Pijnappel RM et al. Supplemental MRI Screening for Women with Extremely Dense Breast Tissue’. N Engl J Med 2019;381:2091-102. DOI: 10.1056/NEJMoa1903986</p> <p>The publication is accompanied by a <a href="https://www.nejm.org/do/10.1056/NEJMdo005617/full/">Quick Take</a> summarizing the study in a short video.</p> </div> </div> <i class="banner-image force-fullsize"> <picture> <!--[if IE 9]><video style="display: none;"><![endif]--> <source srcset="/sites/default/files/styles/header_sm_min_width_1200px/public/2018-06/MYESR_PageBanner6_web.jpg?itok=oiMSj_3M 1x" media="all and (min-width: 1200px)" type="image/jpeg"/> <source srcset="/sites/default/files/styles/header_sm_max_width_1199px/public/2018-06/MYESR_PageBanner6_web.jpg?itok=9DrsuzsI 1x" media="all and (max-width: 1199px)" type="image/jpeg"/> <source srcset="/sites/default/files/styles/header_sm_max_width_1199px/public/2018-06/MYESR_PageBanner6_web.jpg?itok=9DrsuzsI 1x" media="all and (min-width: 992px)" type="image/jpeg"/> <source srcset="/sites/default/files/styles/header_sm_max_width_991px/public/2018-06/MYESR_PageBanner6_web.jpg?itok=sKnv3ZpR 1x" media="all and (max-width: 991px)" type="image/jpeg"/> <source srcset="/sites/default/files/styles/header_sm_max_width_991px/public/2018-06/MYESR_PageBanner6_web.jpg?itok=sKnv3ZpR 1x" media="all and (min-width: 768px)" type="image/jpeg"/> <source srcset="/sites/default/files/styles/header_sm_max_width_767px/public/2018-06/MYESR_PageBanner6_web.jpg?itok=mDUCNuR1 1x" media="all and (max-width: 767px)" type="image/jpeg"/> <!--[if IE 9]></video><![endif]--> <img src="/sites/default/files/styles/header_sm_max_width_767px/public/2018-06/MYESR_PageBanner6_web.jpg?itok=mDUCNuR1" alt="MYESR_PageBanner6_web.jpg" typeof="foaf:Image" class="img-responsive" /> </picture> </i> <span class="a2a_kit a2a_kit_size_32 addtoany_list" data-a2a-url="https://www.myesr.org/article/2610" data-a2a-title="Results of a major breast cancer imaging trial presented at ECR 2019 published in The New England Journal of Medicine"><a class="a2a_button_facebook"></a><a class="a2a_button_twitter"></a></span> Wed, 27 Nov 2019 15:01:47 +0000 myESR 2610 at https://www.myesr.org Hybrid imaging proves to be a trending topic in radiology as CHILI 2.0 sees a rise in viewers https://www.myesr.org/article/2601 <span property="schema:name">Hybrid imaging proves to be a trending topic in radiology as CHILI 2.0 sees a rise in viewers</span> <span rel="schema:author"><span title="View user profile." href="/user/1" lang="" about="/user/1" typeof="schema:Person" property="schema:name" datatype="">myESR</span> </span> <span property="schema:dateCreated" content="2019-11-05T17:39:22+00:00">Tue, 11/05/2019 - 18:39</span> <div class="row p-relative"> <div class="col-xs-12 col-sm-12 col-md-12"> <p class="MsoNormal"><strong><span>The second Conference on Hybrid Imaging Live (CHILI 2.0), which took place on October 25, saw an increase in the number of people tuning in for the virtual meeting in comparison to last year’s debut meeting. A total of 4,064 people registered for CHILI 2.0 compared to 3,515 last year, representing an increase of 16 percent. </span></strong></p> <p class="MsoNormal"><span>The conference, which was organised by the European Society of Hybrid, Molecular and Translational Imaging (ESHI<sup>MT</sup>) and the European Society of Radiology (ESR) was broadcast live from the new state-of-the-art ESR studio in Vienna. Over the course of a fully packed day of lectures, roundtable discussions and interactive Q&amp;As, hybrid imaging experts from Europe and North America delved into a programme of informative and engaging sessions.</span></p> <p class="MsoNormal"><span>All sessions were tailored to varying degrees of expertise and interests, ascending in their level of complexity as the day progressed and were moderated by professional moderator, Mélisande Rouger. The round table discussions and the opportunity for viewers to ask their questions live to the experts added to the engaging format of the conference and ensured that debates were lively and interesting. The programme was complemented by short videos of international hybrid imaging sites and statements of hybrid imaging ambassadors.</span></p> <p class="MsoNormal"><span>President of ESHI<sup>MT</sup>, Prof. Thomas Beyer, who took part in the conference, stated, “I’m delighted with the turnout at this year’s event; it is fantastic to see so many people engaged in hybrid imaging. The advantages of CHILI’s highly accessible online format are obvious and palatable to people from all around the world. Today, we were able to offer this event free of charge to more and more people all over the world, giving everyone with a passion for hybrid imaging the opportunity to participate and learn. I’d like to express my sincere gratitude to the organisers, the team behind the scenes and you, as the audience who made this conference such a success.”</span></p> <p class="MsoNormal"><span>Leading the way in modern congress delivery, ESHI<sup>MT</sup> and ESR are embracing the global shift to find greener and more sustainable congress formats through their organisation of online educational events such as CHILI 2.0. </span></p> <p class="MsoNormal"><span>All lectures from CHILI 2.0 will shortly be available on </span><a href="https://connect.myesr.org/" target="_blank"><span>ESR Connect</span></a><span> for those who missed the conference or wish to re-watch all the highlights.</span></p> </div> </div> <i class="banner-image force-fullsize"> <picture> <!--[if IE 9]><video style="display: none;"><![endif]--> <source srcset="/sites/default/files/styles/header_sm_min_width_1200px/public/2018-06/MYESR_PageBanner6_web.jpg?itok=oiMSj_3M 1x" media="all and (min-width: 1200px)" type="image/jpeg"/> <source srcset="/sites/default/files/styles/header_sm_max_width_1199px/public/2018-06/MYESR_PageBanner6_web.jpg?itok=9DrsuzsI 1x" media="all and (max-width: 1199px)" type="image/jpeg"/> <source srcset="/sites/default/files/styles/header_sm_max_width_1199px/public/2018-06/MYESR_PageBanner6_web.jpg?itok=9DrsuzsI 1x" media="all and (min-width: 992px)" type="image/jpeg"/> <source srcset="/sites/default/files/styles/header_sm_max_width_991px/public/2018-06/MYESR_PageBanner6_web.jpg?itok=sKnv3ZpR 1x" media="all and (max-width: 991px)" type="image/jpeg"/> <source srcset="/sites/default/files/styles/header_sm_max_width_991px/public/2018-06/MYESR_PageBanner6_web.jpg?itok=sKnv3ZpR 1x" media="all and (min-width: 768px)" type="image/jpeg"/> <source srcset="/sites/default/files/styles/header_sm_max_width_767px/public/2018-06/MYESR_PageBanner6_web.jpg?itok=mDUCNuR1 1x" media="all and (max-width: 767px)" type="image/jpeg"/> <!--[if IE 9]></video><![endif]--> <img src="/sites/default/files/styles/header_sm_max_width_767px/public/2018-06/MYESR_PageBanner6_web.jpg?itok=mDUCNuR1" alt="MYESR_PageBanner6_web.jpg" typeof="foaf:Image" class="img-responsive" /> </picture> </i> <span class="a2a_kit a2a_kit_size_32 addtoany_list" data-a2a-url="https://www.myesr.org/article/2601" data-a2a-title="Hybrid imaging proves to be a trending topic in radiology as CHILI 2.0 sees a rise in viewers"><a class="a2a_button_facebook"></a><a class="a2a_button_twitter"></a></span> Tue, 05 Nov 2019 17:39:22 +0000 myESR 2601 at https://www.myesr.org The ESR and ERS call for greater EU focus on lung cancer to reduce deaths and beat cancer https://www.myesr.org/article/2598 <span property="schema:name">The ESR and ERS call for greater EU focus on lung cancer to reduce deaths and beat cancer</span> <span rel="schema:author"><span title="View user profile." href="/user/1" lang="" about="/user/1" typeof="schema:Person" property="schema:name" datatype="">myESR</span> </span> <span property="schema:dateCreated" content="2019-11-05T17:22:03+00:00">Tue, 11/05/2019 - 18:22</span> <div class="row p-relative"> <div class="col-xs-12 col-sm-12 col-md-12"> <p class="MsoNormal"><strong>Brussels, 6 November 2019</strong> – Under the auspices of the Member of the European Parliament (MEP) Claudia Gamon, the European Society of Radiology (ESR), the European Respiratory Society (ERS) and Lung Cancer Europe (LuCE) have joined forces to organise an event at the European Parliament and publish a factsheet that aims to raise awareness of lung cancer and the need for increased visibility of the disease in European Union (EU) policies.</p> <p class="MsoNormal">As November is lung cancer awareness month, and with the soon-to-be Commissioner for Health bearing the responsibility for a <em>Europe’s Beating Cancer Plan</em>, the three organisations are taking this opportunity to bring attention to one of the deadliest cancers in Europe.</p> <p class="MsoNormal">The ESR and ERS believe that the European Commission’s upcoming cancer plan should propose actions to strengthen the approach at every key stage of the disease, be it prevention, early detection, rapid diagnosis, treatment, life as a cancer survivor or palliative care. To raise awareness of this public health issue, the ESR, ERS and LuCE brought together a variety of stakeholders including academics, politicians and policymakers, as well as representatives of industry and pharmaceutical organisations for productive discussions centred on how to tackle the burden of lung cancer in Europe.</p> <p class="MsoNormal">Claudia Gamon, an Austrian MEP from Renew Europe, set the stage for the 90-minute breakfast roundtable, which benefitted from the contributions of leading experts from both the ERS and the ESR in addition to a patient representative from LuCE. The European Parliament is encouraged to adopt a parliamentary resolution for early detection of lung cancer, to emphasise the need for action across Member States in the interest of public health. The European Commission is called upon to include lung cancer in the scope of the EU Cancer Mission and the <em>Europe’s Beating Cancer Plan</em>.</p> <p class="MsoNormal">In addition, new scientific evidence calls for an update of the 2003 Council Recommendation on cancer screening, and for Member States to exchange best practices and gradually implement lung cancer screening programmes while upholding the highest standards of care and patient safety. <span> </span></p> <p class="MsoNormal">The joint effort between our organisations has also enabled the publication and distribution of a factsheet explaining how lung cancer is currently the biggest cancer killer in Europe, and the extent to which mortality can be reduced by implementing simple measures at European Union level.</p> <p class="MsoNormal">You can find the factsheet <a href="https://www.myesr.org/media/5126" target="_blank">here</a>.</p> </div> </div> <i class="banner-image force-fullsize"> <picture> <!--[if IE 9]><video style="display: none;"><![endif]--> <source srcset="/sites/default/files/styles/header_sm_min_width_1200px/public/2018-06/MYESR_PageBanner6_web.jpg?itok=oiMSj_3M 1x" media="all and (min-width: 1200px)" type="image/jpeg"/> <source srcset="/sites/default/files/styles/header_sm_max_width_1199px/public/2018-06/MYESR_PageBanner6_web.jpg?itok=9DrsuzsI 1x" media="all and (max-width: 1199px)" type="image/jpeg"/> <source srcset="/sites/default/files/styles/header_sm_max_width_1199px/public/2018-06/MYESR_PageBanner6_web.jpg?itok=9DrsuzsI 1x" media="all and (min-width: 992px)" type="image/jpeg"/> <source srcset="/sites/default/files/styles/header_sm_max_width_991px/public/2018-06/MYESR_PageBanner6_web.jpg?itok=sKnv3ZpR 1x" media="all and (max-width: 991px)" type="image/jpeg"/> <source srcset="/sites/default/files/styles/header_sm_max_width_991px/public/2018-06/MYESR_PageBanner6_web.jpg?itok=sKnv3ZpR 1x" media="all and (min-width: 768px)" type="image/jpeg"/> <source srcset="/sites/default/files/styles/header_sm_max_width_767px/public/2018-06/MYESR_PageBanner6_web.jpg?itok=mDUCNuR1 1x" media="all and (max-width: 767px)" type="image/jpeg"/> <!--[if IE 9]></video><![endif]--> <img src="/sites/default/files/styles/header_sm_max_width_767px/public/2018-06/MYESR_PageBanner6_web.jpg?itok=mDUCNuR1" alt="MYESR_PageBanner6_web.jpg" typeof="foaf:Image" class="img-responsive" /> </picture> </i> <span class="a2a_kit a2a_kit_size_32 addtoany_list" data-a2a-url="https://www.myesr.org/article/2598" data-a2a-title="The ESR and ERS call for greater EU focus on lung cancer to reduce deaths and beat cancer"><a class="a2a_button_facebook"></a><a class="a2a_button_twitter"></a></span> Tue, 05 Nov 2019 17:22:03 +0000 myESR 2598 at https://www.myesr.org